Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

New study confirms benefits of rimonabant in weight loss

Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight

29 Aug 2004

FDA reinforces use of Sustiva in first-line HIV combination therapy

Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.

26 Aug 2004

Los Angeles County Health Department confirms third West Nile virus victim

Los Angeles County Department of Health Services is reporting a death from locally acquired West Nile Virus. The victim is a 62-year-old male from the eastern region of the county who passed away last week.

23 Aug 2004

Blueberries may lower cholesterol

New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.

23 Aug 2004

Effectiveness of gingko to treat early dementia

Researchers in London are to explore the effectiveness of gingko, a complementary medicine traditionally used to treat circulatory problems, as a treatment for early dementia.

23 Aug 2004

Research will lead to better treatments for mastocytosis

Tens of millions of people know what it's like to suffer the seasonal torment of allergies, when just a whiff of pollen, mold or dust can set off a chain reaction in the body that causes sniffling, sneezing and coughing.

18 Aug 2004

Scopolamine prevents and relieves motion sickness - but possibly with more adverse effects than alternatives

Researchers from the Cochrane Collaboration have analysed all trials of scopolamine for motion sickness. They found 12 trials, mostly done in healthy young men in the navy.

12 Aug 2004

First human cases of West Nile virus in Mississippi

The seven human cases occurred in: Covington (1), Harrison (1), Lincoln (1), Leflore (1), Rankin (2) and Simpson (1) counties; these numbers include the five suspected cases reported last week by the Mississippi State Department of Health.

11 Aug 2004

Death from locally acquired West Nile Virus within Los Angeles County

Laboratory tests confirmed the presence of WNV antibodies in a 91-year-old San Fernando Valley resident who passed away late last week. This is the third reported death for WNV in California and the first for Los Angeles County.

11 Aug 2004

Painless heart attacks often result in greater fatality rates than painful episodes

Painless heart attacks or heart conditions can be commonly overlooked and undertreated at the hospital, often resulting in greater fatality rates than painful episodes.

9 Aug 2004

Knowledge about oral and head and neck cancer is severely lacking in the American public

Most adult Americans know how to light a cigarette and order a drink, but a great number of them are clueless about the consequence of these two destructive habits – oral and head and neck cancer.

9 Aug 2004

Smart drug that targets cancer cells in the brain following removal of a tumor

The use of a "smart" drug that targets cancer cells in the brain following removal of a tumor may provide treatment that can extend the survival of people with the most common form of primary malignant brain tumor, glioblastoma multiforme (GBM).

3 Aug 2004

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.

3 Aug 2004

College freshmen, beware of dorm diseases

High school graduates have more in common with newborn babies than one would think. Although departing the proverbial family nest, incoming college freshmen need vaccinations, too.

2 Aug 2004

Requip significantly reduces periodic leg movements in patients with restless legs syndrome

New data published in the August issue of SLEEP shows that patients with primary Restless Legs Syndrome (RLS) and with periodic leg movements during sleep (PLMS), have fewer awakenings resulting from involuntary kicks when treated with GlaxoSmithKline's Requip (ropinirole HCl).

2 Aug 2004

Rapid detection of anthrax inhalation

Authors of a research letter in this week’s issue of THE LANCET outline progress in the ability to rapidly detect anthrax inhalation in the event of bioterrorist attacks.

29 Jul 2004

Study shows frovatriptan effective in preventing menstrual associated migraine

A study conducted by researchers at Thomas Jefferson University, Philadelphia, and published Tuesday, July 27, 2004, in the journal Neurology, shows that Frova (frovatriptan), a triptan class migraine therapy with a long half life, significantly reduced the incidence of menstrual associated migraines (MAM) in women who took the medication preventively, in advance of anticipated onset of headache.

29 Jul 2004

Chickasaw County residents in need of emergency medical services will now have access to a lifesaving device

Chickasaw County residents in need of emergency medical services will now have access to a lifesaving device, thanks to a Mississippi State Department of Health initiative that allows purchasing and placement of these devices in rural areas of the state.

29 Jul 2004

Definite link between migraine and menstruation

Two new studies shows a definite link between migraine and menstruation. Approximately half of all women who seek clinical treatment for migraines have reported an association between migraine and menstruation, and a recent study by the City of London Migraine Clinic confirms their experience.

26 Jul 2004

Physical symptoms such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer

A new study published July 26, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, finds a patient's symptoms and results of quality of life assessments may provide important clues to an individual patient's prognosis. Psychosocial factors, such as anxiety or spiritual distress, did not predict shorter survival.

26 Jul 2004

Nausea News and Research

Further Reading

New study confirms benefits of rimonabant in weight loss

FDA reinforces use of Sustiva in first-line HIV combination therapy

Los Angeles County Health Department confirms third West Nile virus victim

Blueberries may lower cholesterol

Effectiveness of gingko to treat early dementia

Research will lead to better treatments for mastocytosis

Scopolamine prevents and relieves motion sickness - but possibly with more adverse effects than alternatives

First human cases of West Nile virus in Mississippi

Death from locally acquired West Nile Virus within Los Angeles County

Painless heart attacks often result in greater fatality rates than painful episodes

Knowledge about oral and head and neck cancer is severely lacking in the American public

Smart drug that targets cancer cells in the brain following removal of a tumor

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

College freshmen, beware of dorm diseases

Requip significantly reduces periodic leg movements in patients with restless legs syndrome

Rapid detection of anthrax inhalation

Study shows frovatriptan effective in preventing menstrual associated migraine

Chickasaw County residents in need of emergency medical services will now have access to a lifesaving device

Definite link between migraine and menstruation

Physical symptoms such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News